Ko Fujimori - Search Results

Year	Number of Results
2002	2
2003	3
2004	1
2005	1
2006	1
2007	4
2008	1
2009	2
2010	5
2011	9
2012	8
2013	6
2014	6
2015	3
2016	6
2017	2
2018	3
2019	6
2020	5
2021	9
2022	1

1

Inhibition of Prostaglandin F₂_α Receptors Exaggerates HCl-Induced Lung Inflammation in Mice.

Maehara T, Fujimori K. Maehara T, et al. Among authors: fujimori k. Int J Mol Sci. 2021 Nov 27;22(23):12843. doi: 10.3390/ijms222312843. Int J Mol Sci. 2021. PMID: 34884648 Free PMC article.

2

Promotion of lipogenesis by PPARγ-activated FXR expression in adipocytes.

Shinohara S, Fujimori K. Shinohara S, et al. Among authors: fujimori k. Biochem Biophys Res Commun. 2020 Jun 18;527(1):49-55. doi: 10.1016/j.bbrc.2020.04.075. Epub 2020 Apr 24. Biochem Biophys Res Commun. 2020. PMID: 32446390

3

Protection of 6-OHDA neurotoxicity by PGF_2α through FP-ERK-Nrf2 signaling in SH-SY5Y cells.

Sano A, Maehara T, Fujimori K. Sano A, et al. Among authors: fujimori k. Toxicology. 2021 Feb 28;450:152686. doi: 10.1016/j.tox.2021.152686. Epub 2021 Jan 21. Toxicology. 2021. PMID: 33486071

4

Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum.

Teno N, Iguchi Y, Oda K, Yamashita Y, Masuda A, Fujimori K, Une M, Gohda K. Teno N, et al. Among authors: fujimori k. ACS Med Chem Lett. 2021 Feb 24;12(3):420-425. doi: 10.1021/acsmedchemlett.0c00640. eCollection 2021 Mar 11. ACS Med Chem Lett. 2021. PMID: 33738070 Free PMC article.

5

Porous particles and novel carrier particles with enhanced penetration for efficient pulmonary delivery of antitubercular drugs.

Tse JY, Koike A, Kadota K, Uchiyama H, Fujimori K, Tozuka Y. Tse JY, et al. Among authors: fujimori k. Eur J Pharm Biopharm. 2021 Oct;167:116-126. doi: 10.1016/j.ejpb.2021.07.017. Epub 2021 Aug 5. Eur J Pharm Biopharm. 2021. PMID: 34363979

6

Prostaglandin F_2α receptor antagonist attenuates LPS-induced systemic inflammatory response in mice.

Maehara T, Higashitarumi F, Kondo R, Fujimori K. Maehara T, et al. Among authors: fujimori k. FASEB J. 2020 Nov;34(11):15197-15207. doi: 10.1096/fj.202001481R. Epub 2020 Sep 28. FASEB J. 2020. PMID: 32985737

7

Glycyrrhizic acid suppresses early stage of adipogenesis through repression of MEK/ERK-mediated C/EBPβ and C/EBPδ expression in 3T3-L1 cells.

Yamamoto M, Nagasawa Y, Fujimori K. Yamamoto M, et al. Among authors: fujimori k. Chem Biol Interact. 2021 Sep 1;346:109595. doi: 10.1016/j.cbi.2021.109595. Epub 2021 Jul 21. Chem Biol Interact. 2021. PMID: 34302803

8

Statins attenuate antiviral IFN-β and ISG expression via inhibition of IRF3 and JAK/STAT signaling in poly(I:C)-treated hyperlipidemic mice and macrophages.

Koike A, Tsujinaka K, Fujimori K. Koike A, et al. Among authors: fujimori k. FEBS J. 2021 Jul;288(14):4249-4266. doi: 10.1111/febs.15712. Epub 2021 Feb 4. FEBS J. 2021. PMID: 33452755

9

Design and identification of a new farnesoid X receptor (FXR) partial agonist by computational structure-activity relationship analysis: Ligand-induced H8 helix fluctuation in the ligand-binding domain of FXR may lead to partial agonism.

Gohda K, Iguchi Y, Masuda A, Fujimori K, Yamashita Y, Teno N. Gohda K, et al. Among authors: fujimori k. Bioorg Med Chem Lett. 2021 Jun 1;41:128026. doi: 10.1016/j.bmcl.2021.128026. Epub 2021 Apr 9. Bioorg Med Chem Lett. 2021. PMID: 33839252

10

Formononetin attenuates H₂O₂-induced cell death through decreasing ROS level by PI3K/Akt-Nrf2-activated antioxidant gene expression and suppressing MAPK-regulated apoptosis in neuronal SH-SY5Y cells.

Sugimoto M, Ko R, Goshima H, Koike A, Shibano M, Fujimori K. Sugimoto M, et al. Among authors: fujimori k. Neurotoxicology. 2021 Jul;85:186-200. doi: 10.1016/j.neuro.2021.05.014. Epub 2021 May 30. Neurotoxicology. 2021. PMID: 34077701

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results